What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Disease
Her scientific interests lie mostly in Internal medicine, Risk factor, Prospective cohort study, Relative risk and Myocardial infarction.
The Internal medicine study combines topics in areas such as Endocrinology and Surgery.
Her study in Endocrinology is interdisciplinary in nature, drawing from both Odds ratio and C-reactive protein.
Her Risk factor research incorporates themes from Epidemiology, Lower risk, Blood pressure, Proportional hazards model and Physical therapy.
Her work deals with themes such as Cohort study, Environmental health, Gastroenterology, Hazard ratio and Confounding, which intersect with Prospective cohort study.
As a member of one scientific family, she mostly works in the field of Myocardial infarction, focusing on Disease and, on occasion, Genetics and Genome-wide association study.
Her most cited work include:
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women (5228 citations)
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus (3521 citations)
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events (2878 citations)
What are the main themes of her work throughout her whole career to date?
Julie E. Buring focuses on Internal medicine, Prospective cohort study, Endocrinology, Risk factor and Relative risk.
Julie E. Buring combines subjects such as Surgery and Oncology with her study of Internal medicine.
Her work in Surgery covers topics such as Myocardial infarction which are related to areas like Disease.
Her work in Prospective cohort study addresses issues such as Epidemiology, which are connected to fields such as Gerontology.
Her study connects C-reactive protein and Endocrinology.
Julie E. Buring interconnects Stroke, Blood pressure and Cardiology in the investigation of issues within Risk factor.
She most often published in these fields:
- Internal medicine (86.18%)
- Prospective cohort study (38.36%)
- Endocrinology (22.72%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (86.18%)
- Vitamin D and neurology (11.44%)
- Prospective cohort study (38.36%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Internal medicine, Vitamin D and neurology, Prospective cohort study, Gastroenterology and Disease.
She combines topics linked to Oncology with her work on Internal medicine.
Her Vitamin D and neurology research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Type 2 diabetes, Placebo and Fatty acid.
Her Prospective cohort study study integrates concerns from other disciplines, such as Mortality rate, Epidemiology, Proportional hazards model and Cohort study.
In Body mass index, she works on issues like Risk factor, which are connected to Incidence.
The various areas that she examines in her Randomized controlled trial study include Stroke and Cancer.
Between 2017 and 2021, her most popular works were:
- Analysis of shared heritability in common disorders of the brain (866 citations)
- Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (585 citations)
- Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (376 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Internal medicine, Prospective cohort study, Vitamin D and neurology, Gastroenterology and Randomized controlled trial are her primary areas of study.
Her Internal medicine study typically links adjacent topics like Oncology.
Her Prospective cohort study study also includes
- Cohort study which intersects with area such as Young adult and Quartile,
- Case-control study which is related to area like Cohort, Lung cancer and Relative risk.
Her Vitamin D and neurology study incorporates themes from Placebo and Mood.
She works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Fatty acid and, in certain cases, Systemic inflammation and Inflammation, as a part of the same area of interest.
Her research integrates issues of Obesity, Proportional hazards model and Risk factor in her study of Body mass index.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
